Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2013 Nov;44(11):3013-7.
doi: 10.1161/STROKEAHA.113.001304. Epub 2013 Sep 5.

Apolipoprotein E, statins, and risk of intracerebral hemorrhage

Affiliations
Observational Study

Apolipoprotein E, statins, and risk of intracerebral hemorrhage

Daniel Woo et al. Stroke. 2013 Nov.

Abstract

Background and purpose: Apolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk of ICH, meta-analyses have not consistently shown a statin-induced risk of ICH. Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use.

Methods: The Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS) study is a prospective, demographically matched case-control study of ICH. A similar study of ICH, Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA), was used as a replication cohort. Subjects were classified as normocholesterolemia, HC without statin use, and HC with statin use. Statistical comparisons were performed using Fisher exact test, χ2 tests, and the Breslow-Day test.

Results: The discovery cohort consisted of 558 ICH cases and 1444 controls, and the replication cohort consisted of 1020 ICH cases and 382 controls. The association of lower risk for HC was not attenuated by statin use. Statin use was observed to confer a higher risk for lobar ICH in those carrying ApoE4/E4 and ApoE2/E4 genotypes in both discovery and replication cohorts, and a test for interaction showed a trend towards significance (P=0.11 for statin and ApoE4/E4).

Conclusions: Statin use does not seem to attenuate the association of HC with decreased risk for nonlobar ICH. Our data support a gene-by-drug effect for lobar ICH, but larger sample sizes are needed to confirm the association before any clinical change is warranted.

Clinical trial registration url: http://clinicaltrials.gov. Unique identifier: NCT00930280.

Keywords: apolipoprotein E; epidemiology; genetics; hydroxymethylgutaryl-CoA reductase inhibitors; intracerebral hemorrhage; pharmacogenomics.

PubMed Disclaimer

References

    1. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, et al. Stroke in a biracial population: The excess burden of stroke among blacks. Stroke; a journal of cerebral circulation. 2004;35:426–431. - PubMed
    1. Taylor CL, Yuan Z, Selman WR, Ratcheson RA, Rimm AA. Mortality rates, hospital length of stay, and the cost of treating subarachnoid hemorrhage in older patients: Institutional and geographical differences. Journal of neurosurgery. 1997;86:583–588. - PubMed
    1. Konishi M, Ozawa H, Iida M, Simamoto T, Ueshima H. Epidemiological studies of cerebro- and cardiovascular diseases in the northeast of japan part i. Pathological approach to the study in akita prefecture. Japanese circulation journal. 1976;40:723–728. - PubMed
    1. Ueda K, Hasuo Y, Kiyohara Y, Wada J, Kawano H, Kato I, et al. Intracerebral hemorrhage in a japanese community, hisayama: Incidence, changing pattern during long-term follow-up, and related factors. Stroke; a journal of cerebral circulation. 1988;19:48–52. - PubMed
    1. Yano K, Reed DM, MacLean CJ. Serum cholesterol and hemorrhagic stroke in the honolulu heart program. Stroke; a journal of cerebral circulation. 1989;20:1460–1465. - PubMed

Publication types

Substances

Associated data